Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
25 c » 2 c (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
25 c » 2 c (Expand Search)
-
721
-
722
-
723
-
724
Influence of Acidic pH on Hydrogen and Acetate Production by an Electrosynthetic Microbiome
Published 2014“…Cyclic voltammetry revealed a 250 mV decrease in hydrogen overpotential and a maximum current density of 12.2 mA/cm<sup>2</sup> at −765 mV (0.065 mA/cm<sup>2</sup> sterile control at −800 mV) by the <i>Acetobacterium</i>-dominated community. …”
-
725
-
726
-
727
-
728
-
729
siRNA oligonucleotide specific for PKA causes decreased expression and activity of PKA and ameliorated the high glucose mediated decrease of G6PD activity.
Published 2012“…In <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0049128#pone-0049128-g005" target="_blank">figure 5C</a>, BAEC were transfected with duplex siRNA targeted against PKA (PKA siRNA) or a random sequence (scramble siRNA), after 24 hours, medium was switched to DMEM with 1% serum plus 5.6 mM glucose or 25 mM glucose for 72 hours. …”
-
730
-
731
-
732
-
733
-
734
-
735
-
736
-
737
Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding-5
Published 2011“…Nuclear extracts obtained from HeLa cells were exposed to GAG-hed at indicated concentrations for 10 min before labelled probe addition (Panels B and D). On panel A and C, complex specificity is denoted by competition assays with a 100 fold excess of indicated oligonucleotide competitor. …”
-
738
-
739
-
740